People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

Biopsy showed hepatocellular carcinoma. Management decisions were made. This case was presented at the Harvard Medical School postgraduate course “Primary Care Internal Medicine Principles and ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

Statins, commonly used to lower cholesterol, may significantly reduce the risk of liver cancer in patients with chronic liver disease, a new study suggests. Researchers found that statin use decreased ...

Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy ...

Importance of Defining Recurrence in Hepatocellular Carcinoma: Local or Both Local and Other Intrahepatic Recurrences? The following represents disclosure information provided by the author of this ...

Panelists discuss how emerging evidence suggests that combining transarterial chemoembolization (TACE) with systemic therapy ...

Reply to: Importance of Defining Recurrence in Hepatocellular Carcinoma: Local or Both Local and Other Intrahepatic Recurrences? The following represents disclosure information provided by authors of ...